| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.42B | 109.20B | 104.60B | 90.64B | 73.59B | 74.15B |
| Gross Profit | 17.64B | 16.87B | 15.66B | 12.61B | 11.63B | 11.35B |
| EBITDA | 13.64B | 13.01B | 12.46B | 9.46B | 8.99B | 9.22B |
| Net Income | 6.40B | 5.94B | 5.89B | 5.37B | 3.87B | 3.70B |
Balance Sheet | ||||||
| Total Assets | 112.69B | 115.53B | 106.81B | 100.36B | 89.20B | 84.87B |
| Cash, Cash Equivalents and Short-Term Investments | 45.41B | 47.58B | 43.29B | 39.47B | 34.82B | 32.68B |
| Total Debt | 4.92B | 215.00M | 105.00M | 1.63B | 1.62B | 1.62B |
| Total Liabilities | 22.52B | 23.26B | 20.75B | 21.33B | 17.17B | 17.38B |
| Stockholders Equity | 87.28B | 88.92B | 82.98B | 76.11B | 69.69B | 65.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.61B | 8.25B | 4.93B | 3.42B | 4.97B |
| Operating Cash Flow | 0.00 | 9.84B | 11.92B | 7.77B | 6.03B | 8.38B |
| Investing Cash Flow | 0.00 | -4.50B | -2.97B | -2.62B | -2.62B | -2.56B |
| Financing Cash Flow | 0.00 | -3.05B | -6.17B | -2.26B | -2.22B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥80.04B | 7.83 | 5.20% | 3.67% | -3.78% | -16.61% | |
74 Outperform | ¥143.44B | 10.91 | ― | 2.93% | 1.77% | 117.03% | |
72 Outperform | ¥73.46B | 12.87 | ― | 3.21% | 4.44% | 14.91% | |
71 Outperform | ¥80.53B | 7.82 | ― | 4.95% | -5.89% | 8.95% | |
70 Outperform | ¥56.03B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
68 Neutral | ¥89.38B | 5.17 | ― | 3.88% | -7.35% | 43.31% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |